Free Trial

Beyond Air (XAIR) Competitors

Beyond Air logo
$0.20 -0.02 (-7.14%)
Closing price 04:00 PM Eastern
Extended Trading
$0.19 0.00 (-1.54%)
As of 08:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

XAIR vs. CTSO, HYPR, EDAP, ICCM, MLSS, APT, CTCX, INO, DXR, and ECOR

Should you be buying Beyond Air stock or one of its competitors? The main competitors of Beyond Air include Cytosorbents (CTSO), Hyperfine (HYPR), Edap Tms (EDAP), IceCure Medical (ICCM), Milestone Scientific (MLSS), Alpha Pro Tech (APT), Carmell (CTCX), Inovio Pharmaceuticals (INO), Daxor (DXR), and electroCore (ECOR). These companies are all part of the "medical equipment" industry.

Beyond Air vs. Its Competitors

Cytosorbents (NASDAQ:CTSO) and Beyond Air (NASDAQ:XAIR) are both small-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, analyst recommendations, dividends, profitability, valuation, risk and earnings.

Cytosorbents has a net margin of -41.77% compared to Beyond Air's net margin of -1,258.46%. Cytosorbents' return on equity of -105.04% beat Beyond Air's return on equity.

Company Net Margins Return on Equity Return on Assets
Cytosorbents-41.77% -105.04% -29.18%
Beyond Air -1,258.46%-233.96%-113.92%

Cytosorbents has a beta of 1.19, meaning that its share price is 19% more volatile than the S&P 500. Comparatively, Beyond Air has a beta of 0.22, meaning that its share price is 78% less volatile than the S&P 500.

32.9% of Cytosorbents shares are held by institutional investors. Comparatively, 31.5% of Beyond Air shares are held by institutional investors. 7.3% of Cytosorbents shares are held by company insiders. Comparatively, 19.4% of Beyond Air shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Cytosorbents had 1 more articles in the media than Beyond Air. MarketBeat recorded 3 mentions for Cytosorbents and 2 mentions for Beyond Air. Beyond Air's average media sentiment score of 1.32 beat Cytosorbents' score of 0.08 indicating that Beyond Air is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Cytosorbents
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Beyond Air
1 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Cytosorbents has higher revenue and earnings than Beyond Air. Cytosorbents is trading at a lower price-to-earnings ratio than Beyond Air, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cytosorbents$35.60M2.00-$20.72M-$0.28-4.07
Beyond Air$3.70M4.55-$46.62M-$0.79-0.25

Cytosorbents currently has a consensus price target of $5.50, suggesting a potential upside of 382.46%. Beyond Air has a consensus price target of $1.50, suggesting a potential upside of 669.23%. Given Beyond Air's stronger consensus rating and higher possible upside, analysts clearly believe Beyond Air is more favorable than Cytosorbents.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cytosorbents
0 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
3.00
Beyond Air
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
1 Strong Buy rating(s)
3.33

Summary

Cytosorbents beats Beyond Air on 9 of the 16 factors compared between the two stocks.

Get Beyond Air News Delivered to You Automatically

Sign up to receive the latest news and ratings for XAIR and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding XAIR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

XAIR vs. The Competition

MetricBeyond AirMED IndustryMedical SectorNASDAQ Exchange
Market Cap$18.14M$2.96B$5.56B$9.04B
Dividend YieldN/A2.42%5.25%4.03%
P/E Ratio-0.2521.1127.1820.14
Price / Sales4.55292.18440.78137.14
Price / CashN/A42.7337.5058.41
Price / Book1.157.748.085.60
Net Income-$46.62M-$54.96M$3.16B$248.43M
7 Day Performance8.94%6.04%3.77%5.15%
1 Month Performance-0.86%4.47%3.90%7.62%
1 Year Performance-67.30%6.12%34.22%21.56%

Beyond Air Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
XAIR
Beyond Air
4.2938 of 5 stars
$0.20
-7.1%
$1.50
+669.2%
-62.8%$18.14M$3.70M-0.2570Positive News
Gap Down
CTSO
Cytosorbents
1.9665 of 5 stars
$1.03
-5.5%
$5.50
+434.0%
+9.9%$64.49M$35.60M-3.68220
HYPR
Hyperfine
1.9051 of 5 stars
$0.77
-4.4%
$1.06
+38.6%
-20.2%$59.54M$12.89M-1.42190Gap Down
EDAP
Edap Tms
2.4026 of 5 stars
$1.57
-1.3%
$8.50
+441.4%
-69.7%$58.70M$69.18M-2.53230
ICCM
IceCure Medical
2.1267 of 5 stars
$1.05
-0.5%
$2.50
+138.1%
+43.2%$58.28M$3.29M-3.7560
MLSS
Milestone Scientific
2.7569 of 5 stars
$0.68
+1.5%
$1.25
+83.8%
-3.5%$53.36M$8.61M-9.7130News Coverage
APT
Alpha Pro Tech
1.1067 of 5 stars
$4.78
+0.6%
N/A-11.3%$51.93M$58.18M12.92120
CTCX
Carmell
N/A$2.44
+0.8%
N/A+38.2%$51.01M$32.84K0.0014
INO
Inovio Pharmaceuticals
3.8939 of 5 stars
$1.33
flat
$9.75
+633.1%
-84.1%$48.77M$220K-0.42320News Coverage
Analyst Forecast
High Trading Volume
DXR
Daxor
2.8527 of 5 stars
$9.86
+0.3%
$25.00
+153.5%
+8.1%$47.72MN/A0.0037
ECOR
electroCore
2.3834 of 5 stars
$6.09
-0.3%
$25.50
+318.7%
+25.5%$45.19M$25.18M-3.9050

Related Companies and Tools


This page (NASDAQ:XAIR) was last updated on 7/10/2025 by MarketBeat.com Staff
From Our Partners